Borosil Scientific Ltd Valuation Shifts Signal Price Attractiveness Concerns

Valuation Metrics Signal Elevated Pricing

As of 1 February 2026, Borosil Scientific’s stock closed at ₹109.80, up 3.98% from the previous close of ₹105.60. However, this price appreciation has coincided with a deterioration in valuation grades. The company’s P/E ratio has surged to 53.34, a level that categorises the stock as expensive compared to its historical valuation and industry peers. This is a significant jump from prior assessments that rated the stock as fairly valued.

Similarly, the price-to-book value ratio stands at 2.41, indicating that investors are paying more than twice the book value for the stock. This contrasts with the company’s return on capital employed (ROCE) of 6.91% and return on equity (ROE) of 4.53%, both of which remain modest and do not fully justify the premium multiples.

Enterprise value to EBITDA (EV/EBITDA) is another key metric where Borosil Scientific is trading at 22.02, again higher than many peers in the industrial products sector. For context, Asahi India Glass, a comparable company, trades at an even higher P/E of 81.45 and EV/EBITDA of 33.16, while Borosil Renewables is also very expensive with a P/E of 44.97 and EV/EBITDA of 21.73. Meanwhile, Borosil Ltd, a related entity, is rated fair with a P/E of 34.86 and EV/EBITDA of 17.29, highlighting the relative expensiveness of Borosil Scientific.

Comparative Analysis with Peers and Historical Benchmarks

When benchmarked against its peers, Borosil Scientific’s valuation appears stretched. The industrial products sector typically commands moderate multiples reflecting steady but unspectacular growth prospects. Borosil Scientific’s P/E ratio of 53.34 is well above the sector average, signalling that the market is pricing in significant growth or operational improvements that have yet to materialise.

Historically, the stock’s 52-week high was ₹190.45, and the low was ₹99.70, indicating a wide trading range. The current price near ₹110 suggests a recovery from the lows but still substantially below the peak, which may temper enthusiasm among investors seeking momentum. Moreover, the company’s year-to-date return of -8.54% underperforms the Sensex’s -3.46% return over the same period, while the one-year return of -31.07% starkly contrasts with the Sensex’s positive 7.18% gain, underscoring relative weakness.

Mojo Score and Rating Update Reflect Caution

Borosil Scientific’s MarketsMOJO score currently stands at 23.0, with a Mojo Grade of Strong Sell, upgraded from a Sell rating on 21 January 2026. This downgrade in sentiment reflects concerns over valuation and operational performance. The market capitalisation grade remains low at 3, indicating limited scale relative to larger industrial peers.

The downgrade to Strong Sell despite a recent price rise suggests that the elevated multiples are not supported by fundamentals. Investors should note that the company’s PEG ratio is 0.00, signalling either zero or negative earnings growth expectations, which further questions the justification for the high P/E multiple.

Operational Performance and Return Metrics Lag Behind Valuation

Return ratios remain subdued, with ROCE at 6.91% and ROE at 4.53%, both below industry averages. These metrics indicate that the company is generating modest returns on capital and equity, which do not align with the premium valuation multiples. The enterprise value to capital employed ratio of 2.93 and EV to sales of 2.00 also suggest that the market is pricing in growth or margin expansion that has yet to be realised.

Given the current valuation, investors may find limited margin of safety, especially considering the stock’s underperformance relative to the broader market indices over the past year and year-to-date periods.

Price Momentum and Market Context

Despite the valuation concerns, Borosil Scientific has shown some short-term price momentum. The stock gained 3.49% over the past week, outperforming the Sensex’s 0.90% gain. However, over the last month, the stock declined by 4.89%, slightly worse than the Sensex’s 2.84% fall. This mixed price action reflects investor uncertainty amid broader market volatility and sector-specific challenges.

Longer-term returns remain disappointing, with a one-year loss of 31.07% compared to a 7.18% gain in the Sensex. This underperformance highlights the risks associated with the stock’s elevated valuation, as market participants have not been rewarded with commensurate earnings growth or operational improvements.

Investment Implications and Outlook

For investors, the shift in Borosil Scientific’s valuation from fair to expensive warrants caution. The current P/E of 53.34 and P/BV of 2.41 are high relative to the company’s modest returns and subdued growth outlook. While the stock’s recent price gains may attract momentum traders, fundamental investors should weigh the risk of overpaying against the company’s operational performance and sector dynamics.

Comparisons with peers such as Asahi India Glass and Borosil Renewables reveal that Borosil Scientific is not alone in trading at elevated multiples, but its weaker return ratios and negative PEG ratio suggest less favourable growth prospects. Investors may prefer to consider alternatives within the industrial products sector or other sectors where valuations are more reasonable and fundamentals stronger.

Overall, the valuation deterioration and negative rating outlook imply that Borosil Scientific currently lacks price attractiveness, and investors should approach the stock with prudence, balancing potential upside against valuation risks and market volatility.

Upgrade at special rates, valid only for the next few days. Claim Your Special Rate →